Bakalov V K, Anasti J N, Calis K A,et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure[J]. Reprod Endrocr. 2005,84(4):958.
Lai Ping Cheung, Po Mui Lam, Ingrid Humg Lok, et al. GnRH-antagonist versus long GnRH agonist p rotocol in poor responders undergoing IVF: a randomized controlled trial[J]. Hum Rep rod, 2005,20(3):616.
[9]
Mohamed K,Davies W,Allsopp J,et al. Agonist"flare-up "versus antagonist in the management of poor responders undergoing in vitro fertilization treatment[J]. Fertil Steril,2005,83(2):331.
[10]
Cedrin Durnerin, Grange Dujardin, Laffy, et al. Recombinant human LH supp lementation during GnRH-antagonist administration in IVF / ICSI cycles: a prospective randomized study[J]. Hum Rep rod, 2004,19(9):1979.
[11]
Griesinger, Schultze Mosgau, Dafopoulos, et al. Recombinant luteinizing hormone supp lementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple dose protocol[J]. Hum Rep rod,2005,20(5):1200.
[12]
Stefania Malmusi,Antonio La Marca,Simone Giulini,et al. Comparison of a gonadotrop in-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation[J]. Fertil Steril, 2005, 84(2):402.
[13]
Fasouliotis S J, Laufer N,Sabbagh Ehrlich S,et al. Gonadotrop in-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF[J]. J Assist Rep rod Genet,2003,20:455.
Tarlatzis B C,Zep iridis L,Grimbizis G,et al. Clinical management of low ovarian response to stimulation for IVF: a systematic review [J]. Hum Rep rod Update,2003,9(1):61.
